Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 16 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
4(33.3%)
Phase 1
4(33.3%)
N/A
3(25.0%)
Phase 4
1(8.3%)
12Total
Phase 2(4)
Phase 1(4)
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT02531347Not ApplicableCompleted

Comparison of Telemedical and Conventional Treatment of Hypertension

Role: lead

NCT01213498Phase 2Completed

The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy

Role: lead

NCT00313430Completed

Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease and/ or Hypertension

Role: lead

NCT00801034Phase 1Completed

The Effects of Potassium on Physiological and Cardiovascular Variables in Healthy Persons

Role: lead

NCT01208701Phase 2Completed

The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy

Role: lead

NCT02527837Phase 1Unknown

The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Hypertensive Versus Healthy Subjects

Role: lead

NCT02528422Phase 1Unknown

The Effect of Acyl-Ghrelin on Kidney Function and Blood Pressure in Healthy Volunteers

Role: lead

NCT02355392Completed

Prevalence of Hypertension Using Telemedical Home Blood Pressure Measurements

Role: lead

NCT02078778Not ApplicableUnknown

Central and Peripheral Blood Pressure in Treatment of Obstructive Sleep Apnea.

Role: lead

NCT02078908Phase 1Completed

The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Healthy Humans. A Dose-response Study

Role: lead

NCT01951196Unknown

Nocturnal Blood Pressure - Central and Peripheral 24-h Blood Pressure in Chronic Kidney Disease.

Role: lead

NCT02078765Unknown

Nocturnal Blood Pressure and Hypertension - Central and Peripheral 24-h Blood Pressure.

Role: lead

NCT01951248Not ApplicableUnknown

Central and Peripheral 24-h Blood Pressure Before and After 3 Month of CPAP Treatment in Obstructive Sleep Apnea

Role: lead

NCT01679652Phase 2Completed

The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension

Role: lead

NCT01388088Phase 4Completed

The Effect of Amiloride and Spironolactone in Patients With Hypertension

Role: lead

NCT01136564Phase 2Completed

Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney Disease

Role: lead

All 16 trials loaded